Understanding Acute Liver Injury (ALI), also known as Acute Hepatic Injury or Acute Liver Damage, is crucial for accurate clinical documentation and medical coding. This resource provides information on diagnosing and documenting ALI, including relevant healthcare guidelines, diagnostic criteria, and ICD-10 codes for Acute Hepatic Injury and Acute Liver Damage. Learn about the causes, symptoms, and treatment of ALI for improved patient care and accurate medical records.
Sudden damage to the liver causing inflammation and impaired function.
Jaundice, abdominal pain, nausea, vomiting, fatigue, dark urine, pale stools.
Drug overdose, viral infections, alcohol abuse, autoimmune disorders.
Complete code families applicable to K72.00
| Description | When to use |
|---|---|
| Sudden liver damage due to various causes. | Use for rapid liver function decline within days/weeks due to drugs, toxins, or infections. |
| Chronic, progressive liver scarring. | Code for long-term liver damage leading to impaired function, often due to alcohol or hepatitis. |
| Inflammation of the liver, often due to a virus. | Use for liver inflammation from viral infections (A, B, C), alcohol, or autoimmune disorders. |
Coding acute liver injury without specifying the cause (e.g., alcohol, drug, viral) can lead to claim denials and inaccurate data.
Miscoding chronic liver disease as acute liver injury or vice versa impacts quality metrics and reimbursement.
Insufficient documentation of acute liver injury severity and related complications can hinder accurate coding and CDI efforts.
R/O other causes of liver dysfunction (ICD-10 K70-K77)
Confirm elevated ALT/AST (LOINC 2345-7, 1920-8)
Document injury onset and risk factors
Assess INR and bilirubin for severity (LOINC 6598-7, 1975-2)
Patient presents with signs and symptoms suggestive of acute liver injury (ALI), also known as acute hepatic injury or acute liver damage. Presenting complaints may include jaundice, dark urine, fatigue, nausea, vomiting, abdominal pain or discomfort, particularly in the right upper quadrant, and pruritus. Physical examination may reveal hepatomegaly, right upper quadrant tenderness, or ascites. Laboratory findings often demonstrate elevated liver enzymes, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and bilirubin. The patient's medical history, medication list, recent alcohol consumption, and potential exposure to hepatotoxic agents were reviewed to determine the etiology of the acute liver injury. Differential diagnoses include viral hepatitis, drug-induced liver injury (DILI), alcoholic liver disease, autoimmune hepatitis, ischemic hepatitis, and biliary obstruction. Initial treatment focuses on supportive care, including fluid management, electrolyte correction, and management of complications such as hepatic encephalopathy and coagulopathy. Further investigation, including imaging studies such as ultrasound or CT scan of the abdomen, may be necessary to delineate the underlying cause and guide specific treatment strategies. Patient education on avoiding hepatotoxic substances, including alcohol and certain over-the-counter medications, is crucial. Follow-up liver function tests (LFTs) will be scheduled to monitor the patient's response to treatment and assess liver function recovery. ICD-10 coding will be determined based on the specific etiology identified.
Differentiating acute liver injury patterns is crucial for targeted management. Hepatocellular injury, often indicated by a significant elevation in alanine aminotransferase (ALT) and aspartate aminotransferase (AST), typically points towards damage to the liver cells themselves, as seen in viral hepatitis or drug-induced liver injury. Explore how specific drug-induced liver injury patterns manifest clinically. Cholestatic injury, characterized by elevated alkaline phosphatase (ALP) and bilirubin levels, suggests impaired bile flow, possibly due to gallstones or certain medications. A mixed pattern, showing elevations in both transaminases and cholestatic markers, can indicate processes like alcoholic hepatitis or autoimmune liver disease. Consider implementing a diagnostic algorithm that incorporates liver function tests, imaging studies, and patient history to accurately distinguish between these patterns and guide further investigations. Learn more about the utility of specific serological markers and imaging modalities in evaluating acute liver injury.
Managing acetaminophen-induced acute liver injury requires prompt intervention. The cornerstone of treatment is N-acetylcysteine (NAC), which replenishes glutathione stores and helps prevent further liver damage. Administering NAC within 8 hours of ingestion is ideal for optimal efficacy. Closely monitor liver function tests (LFTs), including AST, ALT, bilirubin, and prothrombin time (PT/INR), along with creatinine and electrolytes. Consider implementing the Rumack-Matthew nomogram to assess the risk of hepatotoxicity and guide NAC administration. In severe cases with hepatic encephalopathy or coagulopathy, transfer to a specialized liver unit for potential liver transplantation may be necessary. Explore how to calculate and interpret the Rumack-Matthew nomogram in different clinical scenarios.
Post-acute liver injury, ongoing monitoring is essential to ensure complete recovery and detect any potential long-term complications. The frequency and type of follow-up depend on the underlying cause and severity of the initial injury. For drug-induced liver injury, regular monitoring of LFTs for several months is crucial. In cases of viral hepatitis, ongoing surveillance for chronic infection or the development of cirrhosis is important. Learn more about the natural history and potential long-term sequelae of different causes of acute liver injury. Consider implementing a personalized follow-up schedule based on patient-specific risk factors and clinical course, which may include periodic LFTs, abdominal ultrasound, and in specific cases, liver biopsy. Explore how non-invasive markers of fibrosis can be incorporated into long-term monitoring strategies.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.